POSTER SESSION I Monday, March 24, 2003   —  9:30 AM - 12:00 Noon Exhibit Hall A - C HEMATOPATHOLOGY 148 Blastic CD43+ Malignancies: Integrated Mophologic and Immunophenotypic Approach for Delineation of Myeloid, Dendritic, T- and NK-Cell Origin (1035) EJ Burks, TM Schroeder, K Foucar, CS Wilson, D Viswanatha, RS Larson University of New Mexico, Albuquerque, NM 149 Interphase FISH for Chronic Lymphocytic Leukemia and Multiple Myeloma (1036) FM Cady, DJ Wolff Medical University of South Carolina, Charleston, SC 150 Kimura's Disease: A Clinicopathologic Study of 21 Cases (1039) H Chen, LDR Thompson, NS Aguilera, SL Abbondanzo Armed Forces Institute of Pathology, Washington, DC 151 Absence of PAX5 Rearrangements in Lymphoplasmacytic Lymphomas by Interphase FISH (1045) JR Cook, NSI Aguilera, S Reshmi-Skarja, SM Gollin, X Huang, SL Abbondanzo, SH Swerdlow University of Pittsburgh School of Medicine, Pittsburgh, PA; Armed Forces Institute of Pathology, Washington, DC; University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA 152 Recurrent Genomic Alterations in Splenic Marginal Zone B-Cell Lymphoma (1063) K Fu, N Palanisamy, WG Sanger, WC Chan, TC Greiner, P Aoun, RSK Chaganti, DD Weisenburger University of Nebraska Medical Center, Omaha, NE; Memorial Sloan-Kettering Cancer Center, New York City, NY 153 Clusterin Expression Distinguishes Follicular Dendritic Cell Tumors from Other Dendritic Cell Neoplasms (1069) KL Grogg, ME Lae, PJ Kurtin, WR Macon Mayo Clinic, Rochester, MN 154 Cytogenetic Differences between Grade 3A and Grade 3B Follicular Lymphoma (1070) CP Hans, BJ Dave, WG Sanger, P Aoun, TC Greiner, WC Chan, JC Lynch, JO Armitage, DD Weisenburger University of Nebraska Medical Center, Omaha, NE 155 Expression of Survivin, Active Caspase-3 and Ki-67 in Bone Marrow during Disease Progression of B-Cell Chronic Lymphocytic Leukemia—A Tissue Microarray Study (1082) QL Hu, X Sun, T McDonnell, LJ Medeiros, S Brisbay, CE Bueso-Ramos Texas University M.D.Anderson Cancer Center, Houston, TX 156 Immunophenotypic Variability of Acute Leukemia a Retrospective Study of Cases Analyzed by Flow Cytometry (1084) HK Islam, US Katta, G Ramaswamy Westchester Medical Center/ New York Medical College, Valhalla, NY 157 Mylotarg(Gemtuzumab Ozogamicin;CMA-676) in AML: Predictive Variables and Response to Treatment (1095) S Kilgore, H Erba, R Valdez, W Finn, B Schnitzer, C Ross University of Michigan, Ann Arbor, MI 158 S-Phase Kinase Associated Protein 2 Is an Objective Tool for Grading Follicular Lymphoma (1107) CZ Liu, R Persad, Y Fan, R Chiarle, S Ibrahim, G Inghirami New York Univ. School of Medicine, New York, NY; University of Torino, Torino, Italy 159 A Short Nucleotide Insertion in the Mcl-1 Is Associated with Rapid Disease Progression in Chronic Lymphocytic Leukemia (1120) O Moshynska, S Viswanathan, A Saxena Royal University Hospital, Saskatoon, SK, Canada 160 Immunophenotypic Changes Commonly Occur in Relapsed Acute Myelogenous Leukemia, as Detected by Multi-Color Flow Cytometry Using a Selected Panel of Antibodies. (1130) R Persad, CZ Liu, S Ibrahim, G Inghirami New York University School of Medicine, New York, NY 161 Immunohistochemical Expression of Oct2 in Non-Hodgkin Lymphomas Evaluated by Tissue Microarray (TMA) (1136) P Ramalingam, W Finn, B Schnitzer, R Valdez University of Michigan, Ann Arbor, MI 162 Characterization of a Novel Gene Identified by cDNA Microarray Analysis of Progressed Follicular Lymphomas (1142) RS Robetorye, SD Jenson, MS Lim, KSJ Elenitoba-Johnson University of Utah Health Sciences Center, Salt Lake City, UT 163 CD10 and Cyclin D1 Expression in Hairy Cell Leukemia (1147) DM Selby, CW Ross, WG Finn, R Valdez, B Schnitzer University of Michigan, Ann Arbor, MI 164 Free Light Chain Multiple Myeloma: Clinical Features and Correlation of a Sensitive Serum Free Light Chain Assay (Freelite [tm]) to Bone Marrow Morphology (1157) B Staggs, L Joseph, S Skinner, A Pappas University of Arkansas for Medical Sciences, Little Rock, AR 165 Prominent Dysplasia and High Proliferation Rate Are Common in Acute Myeloid Leukemia (AML) with inv(16)(p13q22) (1161) X Sun, LJ Medeiros, QL Hu, D Lu, C Bueso-Ramos UT M.D. Anderson Cancer Center, Houston, TX 166 Expression of c-FLIP in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma (1169) P Uherova, J McKay, S Olson, MA Thompson, KS Hamilton Vanderbilt University Medical Center, Nashville, TN 167 The Significance of t (11; 14)(q13; q32) Single Fusion and Double Fusion Signals in 50 Patients with Mantle Cell Lymphoma: A Prospective Clinico-Pathological and Flourescence In Situ Hybridization (FISH) Study (1177) L Wang, J Gu, EJ Schlette, TM Zaidi, SO Reingold, NP Caraway, RL Katz UT M.D.Anderson Cancer Center, Houston, TX 168 Coexistence of Inversion 16 and the Philadelphia Chromosome in Acute and Chronic Leukemia: Report of Six Cases (1182) Y Wu, ML Slovak, DS Snyder, DA Arber University of Kansas Medical Center, Kansas City, KS; City of Hope National Medical Center, Duarte, CA 169 Ultra-Fast Detection of Clonal Immunoglobulin Heavy Chain Gene Rearrangements (IgH-R) by DNA Melting Curve Analysis in B-Cell Malignant Lymphomas: A Prospective Study (1184) D Xu, J Du, C Schultz, H Ratech Albert Einstein Coll Med/Montefiore Med Ctr, Bronx, NY